Khat (Catha Edulis) as a possible cause of autoimmune hepatitis

World Journal of Hepatology

Volumn 6, Issue 3, 2014, Pages 150-154

  Riyaz, Shahzad ^a   Imran, Mohammad ^a   Gleeson, Dermot ^a   Karajeh, Mohammed A ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Acute hepatitis; Autoimmune hepatitis; Drug induced liver injury; Herbs; Khat

Indexed keywords

EID: 84987881031     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v6.i3.150     Document Type: Article

References (30)

1. Griffiths P. Qat use in London: a study of qat use among a sample of Somalis living in London. Home Office drugs prevention initiative. London: Home Office, 1998.
2. Al-Habori M. The potential adverse effects of habitual use of Catha edulis (khat). Expert Opin Drug Saf 2005; 4: 1145-1154 [PMID: 16255671 DOI: 10.1517/14740338.4.6.1145].
3. Al-Mamary M, Al-Habori M, Al-Aghbari AM, Baker MM. Investigation into the toxicological effects of Catha edulis leaves: a short term study in animals. Phytother Res 2002; 16: 127-132 [PMID: 11933113 DOI: 10.1002/ptr.835].
4. Douglas H, Boyle M, Lintzeris N. The health impacts of khat: a qualitative study among Somali-Australians. Med J Aust 2011; 195: 666-669 [PMID: 22171861 DOI: 10.5694/mja11.10166].
5. Brostoff JM, Plymen C, Birns J. Khat-a novel cause of druginduced hepatitis. Eur J Intern Med 2006; 17: 383 [PMID:16864024. DOI: 10.1016/j.ejim.2005.12.010].
6. Stuyt RJ, Willems SM, Wagtmans MJ, van Hoek B. Chewing khat and chronic liver disease. Liver Int 2011; 31: 434-436 [PMID: 21281438 DOI: 10.1111/j.1478-3231.2010.02440.x].
7. Roelandt P, George C, d'Heygere F, Aerts R, Monbaliu D, Laleman W, Cassiman D, Verslype C, van Steenbergen W, Pirenne J, Wilmer A, Nevens F. Acute liver failure secondary to khat (Catha edulis)-induced necrotic hepatitis requiring liver transplantation: case report. Transplant Proc 2011; 43: 3493-3495 [PMID: 22099826 DOI: 10.1016/j.transproceed.201 1.09.032].
8. Chapman MH, Kajihara M, Borges G, O'Beirne J, Patch D, Dhillon AP, Crozier A, Morgan MY. Severe, acute liver injury and khat leaves. N Engl J Med 2010; 362: 1642-1644 [PMID:20427816. DOI: 10.1056/NEJMc0908038].
9. Peevers CG, Moorghen M, Collins PL, Gordon FH, McCune CA. Liver disease and cirrhosis because of Khat chewing in UK Somali men: a case series. Liver Int 2010; 30: 1242-1243[PMID: 20408953 DOI: 10.1111/j.1478-3231.2010.02228.x].
10. D'Souza R, Sinnott P, Glynn MJ, Sabin CA, Foster GR. An unusual form of autoimmune hepatitis in young Somalian men. Liver Int 2005; 25: 325-330 [PMID: 15780057 DOI: 10.1111/j.1478-3231.2005.01088.x].
11. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Büschenfelde KH, Zeniya M. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938 [PMID: 10580593 DOI: 10.1016/S0168-8278(99)80297-9].
12. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005 [PMID: 8406375 DOI: 10.1002/hep.1840180435].
13. Bénichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990; 11: 272-276 [PMID: 2254635 DOI: 10.1016/0168-8278(90)90124-A].
14. Navarro V. Hepatic adverse event nomenclature document (online). Available from URL: http://www.fda.gov/cder/livertox/presentations2005/Vic_Navarro.ppt.
15. Kalix P. Cathinone, a natural amphetamine. Pharmacol Toxicol 1992; 70: 77-86 [PMID: 1508843 DOI: 10.1111/j.1600-0773.1992. tb00434.x].
16. Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to druginduced liver injuries. J Clin Epidemiol 1993; 46: 1323-1330 [PMID: 8229110 DOI: 10.1016/0895-4356(93)90101-6].
17. Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46: 1331-1336 [PMID: 8229111 DOI: 10.1016/0895-4356(93)90102-7].
18. Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 2008; 66: 758-766 [PMID: 19032721 DOI: 10.1111/j.1365-2125.2008.03264.x].
19. Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26: 664-669 [PMID: 9303497 DOI: 10.1002/hep.510260319].
20. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245 [PMID: 7249508 DOI: 10.1038/clpt.1981.154].
21. Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247-254 [PMID: 837643].
22. Teschke R, Wolff A. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate? Regul Toxicol Pharmacol 2011; 59: 1-7 [PMID: 20854865 DOI: 10.1016/j.yrtph.2010.09.006].
23. Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf 2009; 32: 55-68 [PMID: 19132805 DOI: 10.2165/00002].
24. The use of the WHO-UMC system for standardised case causality assessment. Available from: URL: http://whoumc. org/Graphics/24734.pdf.
25. Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C. Herbal hepatotoxicity: suspected cases assessed for alternative causes. Eur J Gastroenterol Hepatol 2013; 25: 1093-1098 [PMID: 23510966 DOI: 10.1097/MEG].
26. Verma S, Kaplowitz N. Diagnosis, management and prevention of drug-induced liver injury. Gut 2009; 58: 1555-1564 [PMID: 19834119 DOI: 10.1136/gut.2008.163675].
27. Fontana RJ. Acute liver failure due to drugs. Semin Liver Dis 2008; 28: 175-187 [PMID: 18452117 DOI: 10.1055/s-2008-1-073117].
28. Chang CY, Schiano TD. Review article: drug hepatotoxicity. Aliment Pharmacol Ther 2007; 25: 1135-1151 [PMID: 17451560 DOI: 10.1111/j.1365-2036.2007.03307.x].
29. Björnsson E, Davidsdottir L. The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice. J Hepatol 2009; 50: 511-517 [PMID: 19155082 DOI: 10.1016/j.jhep.2008.10.021].
30. Teschke R, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. World J Gastroenterol 2013; 19: 2864-2882 [PMID: 23704820].